Penn Medicine Provider
Hematology, Medical Oncology
David M. Mintzer, MD
Accepting new patients
Sees patients age 18 and up
Penn Hematology/Oncology Pennsylvania Hospital
About me
- Chief, Section of Hematology Oncology, Pennsylvania Hospital
- Clinical Professor of Medicine (Hematology-Oncology)
Education and training
- Medical School: Jefferson Medical College
- Residency: Pennsylvania Hospital
- Fellowship: Thomas Jefferson University Hospital
- Fellowship: Memorial Sloan-Kettering Cancer Center
What my patients think about me
1525 reviews
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
June 2025
outstanding physician
June 2025
very personable
June 2025
great doc
June 2025
best ever
My Locations
Abramson Cancer Center Radnor
Penn Hematology/Oncology Pennsylvania Hospital
Qualifications and experience
- Medical Oncology, 1983
- Hematology, 1982
- Internal Medicine, 1980
- American College of Physicians, National
- American Society of Clinical Oncology, National
- American Society of Hematology, National
- Abramson Cancer Center
- Penn Breast Cancer Program
- Recognized annually in Philadelphia magazine's Top Docs issue from 2004 through 2025
Treatments and Conditions
My research
David M. Mintzer But Where is My Doctor? The Increasing and Relentless Fragmentation of Oncology Care , Journal of Clinical Oncology , 41(26): 2023,4313
Mintzer D, Henry D FDA approvals in hematology and oncology, Part II: New oral formulations, RET and MET inhibitors, and CAR T-cell therapies , MDEdge: 2021
Mintzer D, Henry D FDA approvals in hematology and oncology: Novel agents and new tricks for old drugs , MDEdge: 2021
David Mintzer MKSAP 19, Oncology, Sections on lymphoma, melanoma, effects of cancer therapy and survivorship , American College of Physicians: 2021
Deye, DL; Mintzer D MKSAP 19 Audio companion , Oakstone: 2021
Mintzer D MKSAP 19, Oncology, Sections on lymphoma, melanoma, effects of cancer therapy and survivorship , American College of Physicians: 2021
Bryer E, Mintzer D, Henry DH 2019 At a Glance: Hem-Onc U.S. Drug Approvals , MDedge/Hematology and Oncology: 2019
Emily Bryer, Monique Neault, David Mintzer Managing Dying: Medical Care and Decision Making at the Very End-of-Life , Palliative Medicine & Care: Open Access: 2019,DOI: http://dx.doi.org/10.15226/2374-8362/6/1/00180
Bryer E, Mintzer D, Henry D 2018 At A Glance: Recently Approved Therapies in Oncology , MD Edge/Hematology and Oncology : 2019,://mdedge-files-live.s3.us-east-2.amazonaws.com
Deshields TL, Dueck AC, Rogers K, Brown JR, Shanafelt T, Mintzer D, Byrd JC Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance). , Leukemia and Lymphoma : 2019,1-4